



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1144






                                    ANSWERED ON: 
                                

03.12.2021






Study on Ashwagandha for recovery from COVID-19




Vellalath Kochukrishnan Nair. Sreekandan














                        Will the Minister of





AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)


                        be pleased to state:-















                                                    (a)whether the Government has entered into acollaboration with an overseas institution to conduct astudy on use of Ashwagandha for recovery fromCOVID-19;(b) if so, whether the trial will be conducted on 2,000participants in three U.K. based cities and if so, thedetails thereof;(c) whether the Government is considering toconduct trials of various other Indian medicinal herbsfor treating various diseases; and(d) if so, the details thereof?






ANSWER




                                                        THE MINISTER OF AYUSH(SHRI SARBANANDA SONOWAL)(a)	Yes. The Ministry of Ayush, Government of India through its Autonoums Institute i.e. All India Institute of Ayurveda (AIIA), Sarita Vihar, New Delhi has signed an agreement with London School of Hygiene & Tropical Medicine (LSH&TM), UK for conducting the study on “Ashwagandha for promoting recovery from Covid-19in the UK” on 22 July 2021.The study is a Randomized, placebo controlled double blind trial. (b) Yes. The clinical trial will be conducted on 2,000 people in three UK cities—Leicester, Birmingham and London (Southhall and Wembley) to investigate Ashwagandha’sefficacy on COVID-19. In this study, one group of 1000 participants will be administered Ashwagandha (AG) tablets while the second group of 1.000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste, for three months.(c) &(d) No, 	  	********
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113223437







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







